Clinical Trial

Intratympanic Injection of Dexamethasone With Hyaluronic Acid in Treatment of Sudden Sensorineural Hearing Loss

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
* To evaluate efficacy of intratympanic injection of dexamethasone and hyaluronic acid mixture as a treatment modality in cases of sudden sensorineural hearing loss (SSNHL). * To compare outcomes of intratympanic injection of dexamethasone and hyaluronic acid mixture to dexamethasone alone in treatment of SSNHL.
Trial Details
NCT Number NCT06878599
Lead Sponsor Assiut University
Conditions Sudden Sensorineural Hearing Loss (SSNHL)
Enrollment 70 participants
Start Date 2025-05-01
Primary Completion 2027-10 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2025-03-17